Journal Article (Review Article) DZNE-2025-01203

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Springer Heidelberg

European radiology 35(11), 6798 - 6810 () [10.1007/s00330-025-11675-1]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Hypersensitivity reactions to iodine-based, gadolinium-based and ultrasound contrast agents are a heterogeneous group that occur infrequently and can be classified as either immediate or non-immediate. In imaging, most are mild or moderate, while severe reactions are very rare. A standardized risk assessment and close patient monitoring are crucial. In addition to liberal use of supportive treatment by oxygen and volume expansion, the main drugs for treatment of individual reactions include intramuscular adrenaline and H1-antihistamines, with limited indications for short-acting β2-agonists (SABA) like salbutamol or albuterol. As these reactions occur infrequently, these situations often create stress and confusion. During treatment, the stability or progression of the reaction should be constantly assessed, assigning a specific task to each team member. In addition, detailed documentation and correct classification of the severity of such reactions will help improve the risk management in future imaging studies. Regular hands-on training for all personnel involved in managing these reactions is mandatory. To help, the ESUR Contrast Media Safety Committee has reviewed the literature on hypersensitivity reactions and updated its guidance on how to appropriately manage, treat, and document immediate and non-immediate hypersensitivity reactions to contrast media in adults. KEY POINTS: Question Hypersensitivity reactions to contrast media may require immediate action to prevent further damage to the patient. Guidance on management would help improving preparedness. Findings Clear treatment protocols with cards or flowcharts are mandatory. Intramuscular adrenaline is the most important drug for treatment. Documentation should be agent-specific and standardized. Clinical relevance The ESUR Contrast Media Safety Committee has updated its guidance on how to appropriately manage, treat, and document immediate and non-immediate hypersensitivity reactions to contrast media in adults.

Keyword(s): Humans (MeSH) ; Contrast Media: adverse effects (MeSH) ; Drug Hypersensitivity: therapy (MeSH) ; Drug Hypersensitivity: diagnosis (MeSH) ; Drug Hypersensitivity: etiology (MeSH) ; Adult (MeSH) ; Hypersensitivity, Immediate: chemically induced (MeSH) ; Hypersensitivity, Immediate: therapy (MeSH) ; Hypersensitivity, Delayed: chemically induced (MeSH) ; Hypersensitivity, Delayed: therapy (MeSH) ; Clinical protocols ; Contrast media ; Hypersensitivity (delayed) ; Hypersensitivity (immediate) ; Practice guideline ; Contrast Media

Classification:

Contributing Institute(s):
  1. Clinical Neuroimaging (AG Radbruch)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Radbruch
Full Text Collection
Public records
Publications Database


Linked articles:

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Review Article)  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee.
European radiology 35(11), 6811 - 6825 () [10.1007/s00330-025-11676-0] OpenAccess  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS


 Record created 2025-10-29, last modified 2026-01-05